Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yinghui Tong

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Pharmacological Research|September 15, 2009
Altered profiles of gene expression in curcumin-treated rats with experimentally induced myocardial infarctionDongsheng Hong, Xiaowei Zeng, Wei Xu, et al.
Die Pharmazie|March 12, 2011
A novel therapeutic regimen for hepatic fibrosis using the combination of mesenchymal stem cells and baicalinHongxiang Qiao, Yinghui Tong, Hongcan Han, et al.
Translational Cancer Research|February 4, 2022
Jumonji domain containing 5 is a potential prognostic indicator in non-small cell lung cancer patients who received platinum-based chemotherapyXueping Xiang, Xiaojing Ma, Mao Fang, et al.
BMJ Open|December 29, 2020
Cost-effectiveness of pembrolizumab for treatment of platinum-resistant recurrent or metastatic head and neck squamous cell carcinoma in China: an economic analysis based on a randomised, open-label, phase III trialWenxiu Xin, Haiying Ding, Qilu Fang, et al.
Plos One|September 3, 2020
Cost effectiveness of immune checkpoint inhibitors for treatment of non-small cell lung cancer: A systematic reviewHaiying Ding, Wenxiu Xin, Yinghui Tong, et al.
Oncotarget|May 11, 2017
Incidence of menopausal symptoms in postmenopausal breast cancer patients treated with aromatase inhibitorsDongsheng Hong, Ling Bi, Jun Zhou, et al.
Plos One|December 15, 2022
Cost-effectiveness of PARP inhibitors in malignancies: A systematic reviewHaiying Ding, Chaoneng He, Yinghui Tong, et al.
Peerj|October 16, 2023
Dose-sparing effect of lapatinib co-administered with a high-fat enteral nutrition emulsion: preclinical pharmacokinetic studyJunfeng Zhu, Gaoqi Xu, Dihong Yang, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|December 15, 2010
Tanshinone IIA increases recruitment of bone marrow mesenchymal stem cells to infarct region via up-regulating stromal cell-derived factor-1/CXC chemokine receptor 4 axis in a myocardial ischemia modelYinghui Tong, Wei Xu, Hongcan Han, et al.
Journal of Clinical Pharmacology|May 16, 2018
Pharmacokinetic/Pharmacodynamic Analysis of Isavuconazole Against Aspergillus spp. and Candida spp. in Healthy Subjects and Patients With Hepatic or Renal Impairment by Monte Carlo SimulationXiaowei Zheng, Gaoqi Xu, Liqin Zhu, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Pharmacological Research|September 15, 2009
Altered profiles of gene expression in curcumin-treated rats with experimentally induced myocardial infarctionDongsheng Hong, Xiaowei Zeng, Wei Xu, et al.
Die Pharmazie|March 12, 2011
A novel therapeutic regimen for hepatic fibrosis using the combination of mesenchymal stem cells and baicalinHongxiang Qiao, Yinghui Tong, Hongcan Han, et al.
Translational Cancer Research|February 4, 2022
Jumonji domain containing 5 is a potential prognostic indicator in non-small cell lung cancer patients who received platinum-based chemotherapyXueping Xiang, Xiaojing Ma, Mao Fang, et al.
BMJ Open|December 29, 2020
Cost-effectiveness of pembrolizumab for treatment of platinum-resistant recurrent or metastatic head and neck squamous cell carcinoma in China: an economic analysis based on a randomised, open-label, phase III trialWenxiu Xin, Haiying Ding, Qilu Fang, et al.
Plos One|September 3, 2020
Cost effectiveness of immune checkpoint inhibitors for treatment of non-small cell lung cancer: A systematic reviewHaiying Ding, Wenxiu Xin, Yinghui Tong, et al.
Oncotarget|May 11, 2017
Incidence of menopausal symptoms in postmenopausal breast cancer patients treated with aromatase inhibitorsDongsheng Hong, Ling Bi, Jun Zhou, et al.
Plos One|December 15, 2022
Cost-effectiveness of PARP inhibitors in malignancies: A systematic reviewHaiying Ding, Chaoneng He, Yinghui Tong, et al.
Peerj|October 16, 2023
Dose-sparing effect of lapatinib co-administered with a high-fat enteral nutrition emulsion: preclinical pharmacokinetic studyJunfeng Zhu, Gaoqi Xu, Dihong Yang, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|December 15, 2010
Tanshinone IIA increases recruitment of bone marrow mesenchymal stem cells to infarct region via up-regulating stromal cell-derived factor-1/CXC chemokine receptor 4 axis in a myocardial ischemia modelYinghui Tong, Wei Xu, Hongcan Han, et al.
Journal of Clinical Pharmacology|May 16, 2018
Pharmacokinetic/Pharmacodynamic Analysis of Isavuconazole Against Aspergillus spp. and Candida spp. in Healthy Subjects and Patients With Hepatic or Renal Impairment by Monte Carlo SimulationXiaowei Zheng, Gaoqi Xu, Liqin Zhu, et al.
Pageof 2